|
PAR-SN expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.08575428834502E-13 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.83630929643186E-12 |
| Normal-vs-Stage2 |
1.0134999506306E-09 |
| Normal-vs-Stage3 |
4.10390055272103E-10 |
| Normal-vs-Stage4 |
6.8024999999583E-07 |
| Stage1-vs-Stage2 |
3.696000E-01 |
| Stage1-vs-Stage3 |
3.916400E-01 |
| Stage1-vs-Stage4 |
7.844800E-01 |
| Stage2-vs-Stage3 |
9.652200E-01 |
| Stage2-vs-Stage4 |
7.962600E-01 |
| Stage3-vs-Stage4 |
8.358600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.32480701356508E-12 |
| Normal-vs-AfricanAmerican |
2.00499949976063E-10 |
| Normal-vs-Asian |
1.97599999696152E-08 |
| Caucasian-vs-AfricanAmerican |
6.495400E-01 |
| Caucasian-vs-Asian |
8.660200E-02 |
| AfricanAmerican-vs-Asian |
5.137500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
1.49190000353627E-08 |
| Male-vs-Female |
5.087600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.04050000007783E-07 |
| Normal-vs-Extreme_Weight |
7.72881758592803E-12 |
| Normal-vs-Obese |
5.06999997540447E-11 |
| Normal-vs-Extreme_Obese |
6.4263999999925E-05 |
| Normal_Weight-vs-Extreme_Weight |
5.618400E-01 |
| Normal_Weight-vs-Obese |
5.628000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.351400E-01 |
| Extreme_Weight-vs-Obese |
9.944000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.593200E-01 |
| Obese-vs-Extreme_Obese |
4.866000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.05009999584738E-08 |
| Normal-vs-Age(41-60Yrs) |
5.7132998332321E-10 |
| Normal-vs-Age(61-80Yrs) |
2.22044604925031E-16 |
| Normal-vs-Age(81-100Yrs) |
2.19989999550307E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.313600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.009800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.628600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.691580E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.793800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.756400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.75619543749417E-12 |
| Normal-VS-Type2 PRCC |
3.88578058618805E-14 |
| Normal-VS-KIRP CIMP |
1.61870000003894E-06 |
| Normal-VS-Unclassified PRCC |
2.0504709041802E-12 |
| Type1 PRCC-VS-Type2 PRCC |
1.568390E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.170400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.071800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.773400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.736200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.711800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.46549439250521E-14 |
| Normal-vs-N1 |
6.18770001903357E-09 |
| Normal-vs-N2 |
1.70239999999211E-05 |
| N0-vs-N1 |
9.515800E-01 |
| N0-vs-N2 |
1.630950E-01 |
| N1-vs-N2 |
2.872000E-01 |
|
|
